# COPS6

## Overview
COPS6 is a gene that encodes the protein COP9 signalosome subunit 6, a crucial component of the COP9 signalosome (CSN) complex. This complex is involved in the regulation of protein degradation, particularly through the ubiquitin-proteasome pathway. The protein encoded by COPS6 is characterized by an MPN (Mov34 and Pad1p N-terminal) domain, which is essential for its integration into the CSN complex, although it lacks the JAMM motif found in other MPN domain-containing subunits. COPS6 plays a significant role in the deneddylation of cullin-RING E3 ubiquitin ligases, thereby modulating their activity and influencing various cellular processes such as cell cycle control, DNA repair, and signal transduction. The protein is primarily active in the nucleus and cytoplasm, where it contributes to maintaining cellular homeostasis. Dysregulation of COPS6 has been implicated in several cancers, making it a potential target for therapeutic strategies (Wei2003The; Du2023COPS6; Qin2020COP9).

## Structure
COPS6, also known as COP9 signalosome subunit 6, is a component of the COP9 signalosome (CSN) complex, which is involved in the regulation of protein degradation. The protein contains an MPN (Mov34 and Pad1p N-terminal) domain, which is crucial for its integration into the CSN complex, although it lacks the JAMM motif that is present in other MPN domain-containing subunits like CSN5 (Pick2012The; Qin2020COP9). The C-terminal domain of COPS6, referred to as S6CD, is conserved across various species and is sufficient for the assembly and deneddylase activity of the CSN complex, indicating its importance in maintaining the structural integrity of the complex (Pick2012The).

COPS6 is part of the CSN4-5-6-7 subcomplex within the larger CSN structure, contributing to the dynamic regulation of cullin modification, which is essential for cell cycle progression and signal transduction (Qin2020COP9). The CSN complex itself is composed of eight subunits, with COPS6 playing a role in the quaternary structure by interacting with other subunits to form a functional complex (Qin2020COP9). The protein may undergo post-translational modifications, such as phosphorylation, which could influence its function and interactions within the complex (Henke1999ComparisonofhumanCOP9signalosomeand26Sproteasome'lid').

## Function
COPS6, a subunit of the COP9 signalosome (CSN) complex, plays a critical role in regulating protein degradation through the ubiquitin-proteasome pathway. It is involved in the deneddylation of cullin-RING E3 ubiquitin ligases (CRLs), a process essential for modulating their activity. This deneddylation is crucial for the regulation of protein degradation pathways, impacting various cellular processes such as cell cycle control, DNA repair, and signal transduction (Wei2003The; WEI2008The; Qin2020COP9).

COPS6 is primarily active in the nucleus and cytoplasm, where it assists in maintaining cellular homeostasis by influencing the degradation of proteins like the tumor suppressor p53 through stabilization of MDM2 (Liu2024COP9). The CSN complex, including COPS6, is also implicated in the regulation of gene expression and DNA repair, highlighting its involvement in maintaining genome stability and proper cellular function (WEI2008The).

In healthy human cells, the coordinated expression of COPS6 with other COP9 genes is essential for normal physiological processes, particularly those related to mitochondrial biogenesis and the respiratory chain complex. This coordination is crucial for maintaining normal cellular functions and organismal development (Wicker2016Analysis).

## Clinical Significance
COPS6, a component of the COP9 signalosome, is implicated in various cancers due to its role in protein degradation and immune evasion. Overexpression of COPS6 is observed in several cancers, including breast cancer, glioblastoma, colorectal cancer, thyroid cancer, melanoma, hepatocellular carcinoma, and pancreatic cancer (Du2023COPS6). In breast cancer, COPS6 promotes tumor progression by enhancing cell proliferation, migration, and invasion while inhibiting apoptosis. It achieves this by activating the AKT pathway and modulating the expression of apoptotic proteins (Du2023COPS6).

COPS6 also plays a role in immune evasion by reducing CD8+ T cell infiltration through the repression of IL-6 production, contributing to an immunosuppressive tumor microenvironment (Du2023COPS6). This mechanism is significant in breast cancer, where higher COPS6 expression correlates with poorer relapse-free survival (Du2023COPS6).

The gene's expression is negatively regulated by the tumor suppressor p53, and its dysregulation is associated with poor prognosis in cancer patients (Du2023COPS6). These findings suggest that targeting COPS6 could be a potential therapeutic strategy to enhance tumor immunogenicity and treat certain cancers.

## Interactions
COPS6, also known as COP9 signalosome subunit 6, is involved in various protein interactions that influence cellular processes. It is a component of the COP9 signalosome complex and interacts with the SCF (Skp1/Cullin-1/F-box) E3 ubiquitin ligase complex, playing a role in protein degradation. COPS6 stabilizes the Myc protein by interacting with Myc, Fbxw7, and Cullin-1, thereby inhibiting Myc ubiquitination and degradation (Chen2014CSN6). It competes with CSN5 for binding to Cullin-1, affecting Cullin-1's neddylation status, which is crucial for the degradation of Fbxw7 and the stability of Myc (Chen2014CSN6).

COPS6 is also regulated by the HER2-Akt signaling pathway, where Akt phosphorylates COPS6, reducing its ubiquitination and increasing its stability. This interaction negatively impacts p53 activity by stabilizing MDM2, leading to p53 degradation (Xue2012HER2Akt). In breast cancer, COPS6 interacts with proteins such as MDM2, TRIM21, and UBR5, influencing their ubiquitination and degradation, which affects tumor progression and immune evasion (Du2023COPS6). COPS6 also interacts with the HIV-1 Vpr protein, affecting its subcellular localization and cell cycle regulation (Wei1999Making).


## References


[1. (Xue2012HER2Akt) Yuwen Xue, Jian Chen, Hyun-Ho Choi, Liem Phan, Ping-Chieh Chou, Ruiying Zhao, Huiling Yang, Janice Santiago, Mo Liu, Giselle E. Yeung, Sai-Ching J. Yeung, and Mong-Hong Lee. Her2-akt signaling in regulating cop9 signalsome subunit 6 and p53. Cell Cycle, 11(22):4181–4190, November 2012. URL: http://dx.doi.org/10.4161/cc.22413, doi:10.4161/cc.22413. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.4161/cc.22413)

[2. (Pick2012The) Elah Pick, Amnon Golan, Jacob Z. Zimbler, Liquan Guo, Yehonatan Sharaby, Tomohiko Tsuge, Kay Hofmann, and Ning Wei. The minimal deneddylase core of the cop9 signalosome excludes the csn6 mpn− domain. PLoS ONE, 7(8):e43980, August 2012. URL: http://dx.doi.org/10.1371/journal.pone.0043980, doi:10.1371/journal.pone.0043980. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0043980)

[3. (Qin2020COP9) Nanxun Qin, Dongqing Xu, Jigang Li, and Xing Wang Deng. Cop9 signalosome: discovery, conservation, activity, and function. Journal of Integrative Plant Biology, 62(1):90–103, January 2020. URL: http://dx.doi.org/10.1111/jipb.12903, doi:10.1111/jipb.12903. This article has 71 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jipb.12903)

[4. (Chen2014CSN6) Jian Chen, Ji-Hyun Shin, Ruiying Zhao, Liem Phan, Hua Wang, Yuwen Xue, Sean M. Post, Hyun Ho Choi, Jiun-Sheng Chen, Edward Wang, Zhongguo Zhou, Chieh Tseng, Christopher Gully, Guermarie Velazquez-Torres, Enrique Fuentes-Mattei, Giselle Yeung, Yi Qiao, Ping-Chieh Chou, Chun-Hui Su, Yun-Chih Hsieh, Shih-Lan Hsu, Kazufumi Ohshiro, Tattym Shaikenov, Huamin Wang, Sai-Ching Jim Yeung, and Mong-Hong Lee. Csn6 drives carcinogenesis by positively regulating myc stability. Nature Communications, November 2014. URL: http://dx.doi.org/10.1038/ncomms6384, doi:10.1038/ncomms6384. This article has 57 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/ncomms6384)

[5. (Wicker2016Analysis) Christina A. Wicker and Tadahide Izumi. Analysis of rna expression of normal and cancer tissues reveals high correlation of cop9 gene expression with respiratory chain complex components. BMC Genomics, December 2016. URL: http://dx.doi.org/10.1186/s12864-016-3313-y, doi:10.1186/s12864-016-3313-y. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12864-016-3313-y)

[6. (Wei2003The) Ning Wei and Xing Wang Deng. The cop9 signalosome. Annual Review of Cell and Developmental Biology, 19(1):261–286, November 2003. URL: http://dx.doi.org/10.1146/annurev.cellbio.19.111301.112449, doi:10.1146/annurev.cellbio.19.111301.112449. This article has 389 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1146/annurev.cellbio.19.111301.112449)

[7. (Liu2024COP9) Jiahui Liu, Dexing Han, Junfeng Xuan, Jinye Xie, Weijia Wang, Quan Zhou, and Kang Chen. Cop9 signalosome complex is a prognostic biomarker and corresponds with immune infiltration in hepatocellular carcinoma. Aging, 16(6):5264–5287, March 2024. URL: http://dx.doi.org/10.18632/aging.205646, doi:10.18632/aging.205646. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.18632/aging.205646)

[8. (Henke1999ComparisonofhumanCOP9signalosomeand26Sproteasome'lid') Wolfgang Henke, Katherine Ferrell, Dawadschargal Bech-Otschir, Michael Seeger, Rüdiger Schade, Peter Jungblut, Michael Naumann, and Wolfgang Dubiel. Comparison of human cop9 signalosome and 26s proteasome 'lid'. Molecular Biology Reports, 26(1/2):29–34, 1999. URL: http://dx.doi.org/10.1023/A:1006991419464, doi:10.1023/a:1006991419464. This article has 122 citations and is from a peer-reviewed journal.](https://doi.org/10.1023/A:1006991419464)

[9. (Du2023COPS6) Wen-qi Du, Zhi-man Zhu, Xin Jiang, Meng-jie Kang, and Dong-sheng Pei. Cops6 promotes tumor progression and reduces cd8+ t cell infiltration by repressing il-6 production to facilitate tumor immune evasion in breast cancer. Acta Pharmacologica Sinica, 44(9):1890–1905, April 2023. URL: http://dx.doi.org/10.1038/s41401-023-01085-8, doi:10.1038/s41401-023-01085-8. This article has 5 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41401-023-01085-8)

[10. (Wei1999Making) Ning Wei and Xing-Wang Deng. Making sense of the cop9 signalosome: a regulatory protein complex conserved from arabidopsis to human. Trends in Genetics, 15(3):98–103, March 1999. URL: http://dx.doi.org/10.1016/s0168-9525(98)01670-9, doi:10.1016/s0168-9525(98)01670-9. This article has 175 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0168-9525(98)01670-9)

[11. (WEI2008The) N WEI, G SERINO, and X DENG. The cop9 signalosome: more than a protease. Trends in Biochemical Sciences, 33(12):592–600, December 2008. URL: http://dx.doi.org/10.1016/j.tibs.2008.09.004, doi:10.1016/j.tibs.2008.09.004. This article has 328 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.tibs.2008.09.004)